Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Crit Care Clin. 2013 Jan;29(1):51–65. doi: 10.1016/j.ccc.2012.10.007

Figure 2.

Figure 2

In the MENDS trial dexmedetomidine significantly reduced the prevalence of delirium over time. The sample size changes with study day as patients were extubated, died, discharged from the ICU or did not have delirium assessed. Reproduced with permission from Pandharipande et al., Critical Care 2010; 14: R38.